Skip to main content
Journal ArticleOPEN ACCESS

Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World

  • Goldstein D
  • Sarfaty M
The Oncologist (2016) 21(8) 907-909
DOI: 10.1634/theoncologist.2016-0106
13Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The U.S. must assess its pricing and reimbursement system for prescription drugs. The current system is attracting intense scrutiny for various reasons. Drug pricing and reimbursement mechanisms used in other countries are described to assess what an optimal system should entail.

Cite

CITATION STYLE

APA

Goldstein, D. A., & Sarfaty, M. (2016). Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World. The Oncologist, 21(8), 907–909. https://doi.org/10.1634/theoncologist.2016-0106

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free